Jointstem

Nature Cell is a South Korean biotechnology company specializing in the development of regenerative medicine and stem cell therapies. The company's lead candidate, Jointstem, is an autologous adipose-derived mesenchymal stem cell therapy designed to treat degenerative osteoarthritis through a simple intra-articular injection. Beyond orthopedics, Nature Cell is leveraging its proprietary stem cell technology to target complex conditions such as Alzheimer's disease and vascular disorders. The company operates a robust research and development infrastructure focused on advancing cell-based solutions from clinical trials toward global commercialization.